Both warm water tail-withdrawal and respiratory assays have been used to characterize the behavioral effects of various opioid compounds in monkeys. In particular, both assays serve as valid in vivo endpoints for studying the efficacy and selectivity of opioid agonists and the characteristics of opioid antagonists. We have further established an experimental model of inflammatory pain as well as intrathecal and intracisternal injection techniques in monkeys. The proposed research will provide a valuable opportunity to enhance the pharmacological study of pain and opioids in non-human primates. Although there are many interesting findings from rodent studies, it is not clear to what extent they can be replicated and applied to primate species. It is important to conduct monkey studies for characterizing novel, experimental compounds, which have been proposed as better analgesics with less side effects in rodents. This series of proposed studies has several aims including studying different aspects of nociceptive mechanisms, evaluating distinct or newly developed opioid agonists and antagonists, and evaluating the roles of other receptor populations in nociceptive transmission. These studies will also clarify the site(s) of action of novel analgesics, comparing the antinociceptive efficacy of exogenous and endogenous opioid ligands; they will study the non-opioid influence of certain important pain-related substances (e.g. serotonin) for their influence on opioid actions in primates. They will provide a better understanding of opioid pharmacology in general and make a substantial contribution to pain research in primates.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA000254-31
Application #
6647293
Study Section
Special Emphasis Panel (ZDA1)
Project Start
2002-08-15
Project End
2003-06-30
Budget Start
Budget End
Support Year
31
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Moses, Tabitha E H; Lundahl, Leslie H; Greenwald, Mark K (2018) Factors associated with sedative use and misuse among heroin users. Drug Alcohol Depend 185:10-16
Reilly, Mark P; Berndt, Sonja I; Woods, James H (2016) On the nature of directed behavior to drug-associated light cues in rhesus monkeys (Macaca mulatta). Behav Anal (Wash D C) 16:200-209
Woodcock, Eric A; Lundahl, Leslie H; Stoltman, Jonathan J K et al. (2015) Progression to regular heroin use: examination of patterns, predictors, and consequences. Addict Behav 45:287-93
Stoltman, Jonathan J K; Woodcock, Eric A; Lister, Jamey J et al. (2015) Heroin delay discounting: Modulation by pharmacological state, drug-use impulsivity, and intelligence. Exp Clin Psychopharmacol 23:455-63
Stoltman, Jonathan J K; Woodcock, Eric A; Lister, Jamey J et al. (2015) Exploration of the telescoping effect among not-in-treatment, intensive heroin-using research volunteers. Drug Alcohol Depend 148:217-20
Mancha, Brent Edward; Hulbert, Alicia; Latimer, William W (2012) A latent class analysis of alcohol abuse and dependence symptoms among Puerto Rican youth. Subst Use Misuse 47:429-41
Moynihan, Humphrey A; Derrick, Ian; Broadbear, Jillian H et al. (2012) Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible ? opioid receptor antagonist effects. J Med Chem 55:9868-74
Mancha, Brent E; Rojas, Vanessa C; Latimer, William W (2012) Alcohol use, alcohol problems, and problem behavior engagement among students at two schools in northern Mexico. Alcohol 46:695-701
Pichika, Rama; Jewett, Douglas M; Sherman, Philip S et al. (2010) Synthesis and in vivo brain distribution of carbon-11-labeled ?-opioid receptor agonists. Nucl Med Biol 37:989-96
Cooper, Ziva D; Shi, Yong-Gong; Woods, James H (2010) Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats. Psychopharmacology (Berl) 212:369-78

Showing the most recent 10 out of 22 publications